Prognosticating metastatic osteosarcoma treated with uniform chemotherapy protocol without high dose methotrexate and delayed metastasectomy: a single center experience of 102 patients

Nataraj V.; Rastogi S.; Khan S. A.; Sharma M. C.; Agarwala S.; Vishnubhatla S.; Bakhshi S.

首页> 外文期刊>Clinical & translational oncology : >Prognosticating metastatic osteosarcoma treated with uniform chemotherapy protocol without high dose methotrexate and delayed metastasectomy: a single center experience of 102 patients

【24h】

Prognosticating metastatic osteosarcoma treated with uniform chemotherapy protocol without high dose methotrexate and delayed metastasectomy: a single center experience of 102 patients

机译：不采用大剂量氨甲蝶呤和延迟转移的统一化疗方案预后转移性骨肉瘤的预后：102名患者的单中心经验

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Data on prognostic factors in patients with metastatic osteosarcoma treated with uniform chemotherapy protocol are lacking. The objective of this study was to analyze demographic data, treatment outcome and prognostic factors for patients with metastatic osteosarcoma at our center treated with a uniform chemotherapy protocol without high dose methotrexate.

机译：缺乏统一化疗方案治疗转移性骨肉瘤患者预后的数据。这项研究的目的是分析在我们中心接受统一化疗方案但无高剂量甲氨蝶呤治疗的转移性骨肉瘤患者的人口统计学数据，治疗结果和预后因素。

著录项

来源
《Clinical & translational oncology :》 |2016年第9期|共8页
作者
Nataraj V.; Rastogi S.; Khan S. A.; Sharma M. C.; Agarwala S.; Vishnubhatla S.; Bakhshi S.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词
Delayed metastasectomy; Metastatic osteosarcoma; Without high dose methotrexate;

机译：延迟转移术;转移性骨肉瘤;无高剂量甲氨蝶呤;

相似文献

外文文献
中文文献
专利

1. Prognosticating metastatic osteosarcoma treated with uniform chemotherapy protocol without high dose methotrexate and delayed metastasectomy: a single center experience of 102 patients [J] . Nataraj V., Rastogi S., Khan S. A., Clinical & translational oncology : . 2016,第9期

机译：不采用大剂量氨甲蝶呤和延迟转移的统一化疗方案预后转移性骨肉瘤的预后：102名患者的单中心经验
2. Non- High Dose -Methotrexate (HD-MTX) Based, Dose-Dense (DD), Combination, Chemotherapy(CT) in 83 Metastatic Osteosarcoma Patients: A Tertiary Care Centre Experience from India [J] . Bajpai J., Talreja V., Karpe A., Pediatric blood & cancer . 2016,第Suppla3期

机译：基于非高剂量甲氨蝶呤（HD-MTX），剂量密集（DD），联合化疗（CT）的83例转移性骨肉瘤患者：印度三级护理中心的经验
3. Non- High Dose -Methotrexate (HD-MTX) Based, Dose-Dense (DD), Combination, Chemotherapy(CT) in 243 Non-Metastatic Osteosarcoma Patients: A Tertiary Care Centre Experience from India [J] . Bajpai J., Talreja V., Karpe A., Pediatric blood & cancer . 2016,第Suppla3期

机译：基于非高剂量甲氨蝶呤（HD-MTX），剂量密集（DD），联合化疗（CT）的243例非转移性骨肉瘤患者：印度三级护理中心的经验
4. A SINGLE-CENTER EXPERIENCE USING CHEMOTHERAPY WITH MELPHALAN-DEXAMETHASONE (M-DEX) IN PATIENTS WITH AL AMYLOIDOSIS AND ADVANCED ORGAN INVOLVEMENT NOT ELIGIBLE FOR HIGH-DOSE MELPHALAN THERAPY (HDM) [C] . U. Hegenbart, T. Bochtler, J.B. Dengler, International Symposium on Amyloidosis . 2008

机译：使用化学疗法的单中心经验与Melphalan-Dexamethasone（M-DEX）的Al淀粉样蛋白病和先进器官参与没有资格获得高剂量Melphalan治疗（HDM）
5. Outcomes in Treatment-Naïve Patients With Metastatic Extremity Osteosarcoma Treated With OGS-12 a Novel Non–High-Dose Methotrexate–Based Dose-Dense Combination Chemotherapy in a Tertiary Care Cancer Center [O] . Jyoti Bajpai, Arun Chandrasekharan, Vijai Simha, 2018

机译：三级护理癌症中心接受基于OGS-12的新型非大剂量甲氨蝶呤剂量-致密联合化疗OGS-12治疗的初治转移性骨肉瘤患者的治疗结果
6. Comparative Outcome of Thai Pediatric Osteosarcoma Treated with Two Protocols: the Role of High-Dose Methotrexate (HDMTX) in a Single Institute Experience [O] . Worawut Choeyprasert, Samart Pakakasama, Nongnuch Sirachainan, 2014

机译：用两种协议治疗的泰国儿科骨肉瘤的比较结果：高剂量甲氨蝶呤（HDMTX）在单一研究所经验中的作用

Prognosticating metastatic osteosarcoma treated with uniform chemotherapy protocol without high dose methotrexate and delayed metastasectomy: a single center experience of 102 patients

摘要

著录项

相似文献

相关主题

期刊订阅